Follow
Katsuhiko Shimizu
Katsuhiko Shimizu
Associate Professor of Kawasaki Medical School
Verified email at med.kawasaki-m.ac.jp
Title
Cited by
Cited by
Year
Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer
K Shimizu, M Nakata, Y Hirami, T Yukawa, A Maeda, K Tanemoto
Journal of Thoracic Oncology 5 (5), 585-590, 2010
2782010
Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT
K Shimizu, N Ikeda, M Tsuboi, T Hirano, H Kato
Lung cancer 51 (2), 173-179, 2006
1552006
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
R Okita, A Maeda, K Shimizu, Y Nojima, S Saisho, M Nakata
Cancer Immunology, Immunotherapy 66, 865-876, 2017
1462017
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata
World journal of surgical oncology 13, 1-8, 2015
1122015
Adoptive immunotherapy of cancer using activated autologous lymphocytes-current status and new strategies
Y Yamaguchi, A Ohshita, Y Kawabuchi, K Ohta, K Shimizu, K Minami, ...
Human Cell 16, 183-189, 2003
872003
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
R Okita, T Yukawa, Y Nojima, A Maeda, S Saisho, K Shimizu, M Nakata
Cancer Immunology, Immunotherapy 65, 499-509, 2016
672016
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy
S Saisho, K Yasuda, A Maeda, T Yukawa, R Okita, Y Hirami, K Shimizu, ...
Interactive cardiovascular and thoracic surgery 16 (2), 166-172, 2013
652013
Serum antibody against NY-ESO-1 and XAGE1 antigens potentially predicts clinical responses to anti–programmed cell death-1 therapy in NSCLC
Y Ohue, K Kurose, T Karasaki, M Isobe, T Yamaoka, J Futami, I Irei, ...
Journal of Thoracic Oncology 14 (12), 2071-2083, 2019
422019
Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2
Y Yamaguchi, E Miyahara, A Ohshita, Y Kawabuchi, K Ohta, K Shimizu, ...
British journal of cancer 89 (10), 1876-1884, 2003
402003
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata
OncoTargets and therapy, 153-163, 2016
382016
Contrasting effects of the cytotoxic anticancer drug gemcitabine and the EGFR tyrosine kinase inhibitor gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D …
R Okita, D Wolf, K Yasuda, A Maeda, T Yukawa, S Saisho, K Shimizu, ...
PLoS One 10 (10), e0139809, 2015
372015
Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
A Maeda, M Nakata, K Yasuda, T Yukawa, S Saisho, R Okita, Y Hirami, ...
Oncology reports 29 (1), 39-44, 2013
362013
Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer
K Shimizu, R Okita, S Saisho, T Yukawa, A Maeda, Y Nojima, M Nakata
Annals of Nuclear Medicine 29, 854-860, 2015
352015
Cavernous hemangioma of the rib
K Shimizu, Y Yamashita, J Hihara, Y Seto, T Toge
The Annals of thoracic surgery 74 (3), 932-934, 2002
332002
Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small …
K Shimizu, T Yukawa, Y Hirami, R Okita, S Saisho, A Maeda, K Yasuda, ...
Targeted oncology 8, 237-242, 2013
312013
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
K Shimizu, R Okita, S Saisho, A Maeda, Y Nojima, M Nakata
Cancer Management and Research, 741-750, 2017
282017
Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer
K Shimizu, R Okita, S Saisho, T Yukawa, A Maeda, Y Nojima, M Nakata
Therapeutics and clinical risk management, 1555-1561, 2015
282015
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
R Okita, K Shimizu, Y Nojima, T Yukawa, A Maeda, S Saisho, M Nakata
Oncology reports 34 (6), 2864-2870, 2015
272015
Clinical significance of the tumor microenvironment in non-small cell lung cancer
K Shimizu, R Okita, M Nakata
Annals of translational medicine 1 (2), 2013
272013
Extra‐abdominal desmoid tumor presenting as an intrathoracic tumor: Case report and literature review
Y Takeshima, F Nakayori, T Nakano, K Shimizu, Y Yamashita, T Toge, ...
Pathology international 51 (10), 824-828, 2001
262001
The system can't perform the operation now. Try again later.
Articles 1–20